These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 19008315

  • 1. Blockade of estrogen receptor signaling inhibits growth and migration of medulloblastoma.
    Belcher SM, Ma X, Le HH.
    Endocrinology; 2009 Mar; 150(3):1112-21. PubMed ID: 19008315
    [Abstract] [Full Text] [Related]

  • 2. Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role?
    Ciucci A, Meco D, De Stefano I, Travaglia D, Zannoni GF, Scambia G, Riccardi R, Saran A, Mancuso M, Gallo D.
    PLoS One; 2014 Mar; 9(7):e101623. PubMed ID: 25000562
    [Abstract] [Full Text] [Related]

  • 3. Estrogen Receptor-β Up-Regulates IGF1R Expression and Activity to Inhibit Apoptosis and Increase Growth of Medulloblastoma.
    Cookman CJ, Belcher SM.
    Endocrinology; 2015 Jul; 156(7):2395-408. PubMed ID: 25885794
    [Abstract] [Full Text] [Related]

  • 4. Estrogen and soy isoflavonoids decrease sensitivity of medulloblastoma and central nervous system primitive neuroectodermal tumor cells to chemotherapeutic cytotoxicity.
    Belcher SM, Burton CC, Cookman CJ, Kirby M, Miranda GL, Saeed FO, Wray KE.
    BMC Pharmacol Toxicol; 2017 Sep 06; 18(1):63. PubMed ID: 28877739
    [Abstract] [Full Text] [Related]

  • 5. Estrogen receptor α mediates proliferation of osteoblastic cells stimulated by estrogen and mechanical strain, but their acute down-regulation of the Wnt antagonist Sost is mediated by estrogen receptor β.
    Galea GL, Meakin LB, Sugiyama T, Zebda N, Sunters A, Taipaleenmaki H, Stein GS, van Wijnen AJ, Lanyon LE, Price JS.
    J Biol Chem; 2013 Mar 29; 288(13):9035-48. PubMed ID: 23362266
    [Abstract] [Full Text] [Related]

  • 6. Src Inhibition with saracatinib reverses fulvestrant resistance in ER-positive ovarian cancer models in vitro and in vivo.
    Simpkins F, Hevia-Paez P, Sun J, Ullmer W, Gilbert CA, da Silva T, Pedram A, Levin ER, Reis IM, Rabinovich B, Azzam D, Xu XX, Ince TA, Yang JY, Verhaak RG, Lu Y, Mills GB, Slingerland JM.
    Clin Cancer Res; 2012 Nov 01; 18(21):5911-23. PubMed ID: 22896656
    [Abstract] [Full Text] [Related]

  • 7. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
    Liu C, Liao Y, Fan S, Tang H, Jiang Z, Zhou B, Xiong J, Zhou S, Zou M, Wang J.
    Med Oncol; 2015 Apr 01; 32(4):104. PubMed ID: 25744245
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rapid signaling actions of environmental estrogens in developing granule cell neurons are mediated by estrogen receptor ß.
    Le HH, Belcher SM.
    Endocrinology; 2010 Dec 01; 151(12):5689-99. PubMed ID: 20926581
    [Abstract] [Full Text] [Related]

  • 10. Estrogen receptor beta in the paraventricular nucleus of hypothalamus regulates the neuroendocrine response to stress and is regulated by corticosterone.
    Isgor C, Cecchi M, Kabbaj M, Akil H, Watson SJ.
    Neuroscience; 2003 Dec 01; 121(4):837-45. PubMed ID: 14580933
    [Abstract] [Full Text] [Related]

  • 11. Targeting estrogen receptor subtypes (ERα and ERβ) with selective ER modulators in ovarian cancer.
    Chan KK, Leung TH, Chan DW, Wei N, Lau GT, Liu SS, Siu MK, Ngan HY.
    J Endocrinol; 2014 May 01; 221(2):325-36. PubMed ID: 24819599
    [Abstract] [Full Text] [Related]

  • 12. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
    Siegfried JM, Farooqui M, Rothenberger NJ, Dacic S, Stabile LP.
    Oncotarget; 2017 Apr 11; 8(15):24063-24076. PubMed ID: 28445992
    [Abstract] [Full Text] [Related]

  • 13. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression.
    Harrington WR, Sheng S, Barnett DH, Petz LN, Katzenellenbogen JA, Katzenellenbogen BS.
    Mol Cell Endocrinol; 2003 Aug 29; 206(1-2):13-22. PubMed ID: 12943986
    [Abstract] [Full Text] [Related]

  • 14. Estrogen increases smooth muscle expression of alpha2C-adrenoceptors and cold-induced constriction of cutaneous arteries.
    Eid AH, Maiti K, Mitra S, Chotani MA, Flavahan S, Bailey SR, Thompson-Torgerson CS, Flavahan NA.
    Am J Physiol Heart Circ Physiol; 2007 Sep 29; 293(3):H1955-61. PubMed ID: 17644575
    [Abstract] [Full Text] [Related]

  • 15. 2-Methoxyestradiol, an endogenous 17β-estradiol metabolite, inhibits microglial proliferation and activation via an estrogen receptor-independent mechanism.
    Schaufelberger SA, Rosselli M, Barchiesi F, Gillespie DG, Jackson EK, Dubey RK.
    Am J Physiol Endocrinol Metab; 2016 Mar 01; 310(5):E313-22. PubMed ID: 26732685
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of ERβ induces resistance to cisplatin by enhancing Rad51-mediated DNA repair in human medulloblastoma cell lines.
    Wilk A, Waligorska A, Waligorski P, Ochoa A, Reiss K.
    PLoS One; 2012 Mar 01; 7(3):e33867. PubMed ID: 22439007
    [Abstract] [Full Text] [Related]

  • 17. Paracrine-acting adiponectin promotes mammary epithelial differentiation and synergizes with genistein to enhance transcriptional response to estrogen receptor β signaling.
    Rahal OM, Simmen RC.
    Endocrinology; 2011 Sep 01; 152(9):3409-21. PubMed ID: 21712365
    [Abstract] [Full Text] [Related]

  • 18. Ginsenoside Rh2 inhibits proliferation and migration of medulloblastoma Daoy by down-regulation of microRNA-31.
    Chen Y, Shang H, Zhang S, Zhang X.
    J Cell Biochem; 2018 Aug 01; 119(8):6527-6534. PubMed ID: 29377269
    [Abstract] [Full Text] [Related]

  • 19. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
    Greenberger LM, Annable T, Collins KI, Komm BS, Lyttle CR, Miller CP, Satyaswaroop PG, Zhang Y, Frost P.
    Clin Cancer Res; 2001 Oct 01; 7(10):3166-77. PubMed ID: 11595711
    [Abstract] [Full Text] [Related]

  • 20. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
    Katzenellenbogen BS, Choi I, Delage-Mourroux R, Ediger TR, Martini PG, Montano M, Sun J, Weis K, Katzenellenbogen JA.
    J Steroid Biochem Mol Biol; 2000 Nov 30; 74(5):279-85. PubMed ID: 11162936
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.